Stock & Company Details
Forte Biosciences Inc $FBRX
Price:
46,691,331
20M
$973M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-0.33
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
FBRX technical indicators
Latest Forte Biosciences Inc (FBRX) technical indicators as of 2026-07-21: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
84.25 2.4%
MACD:
7.68 5.9%
SMA 50:
$24.48 2.0%
SMA 200:
$24.22 0.8%
EMA 20:
$35.30 4.8%
Bollinger Bands:
56.40 / 6.46
Stochastic:
91.94 0.3%
ADX 14:
50.34 4.8%
ATR 14:
4.06 2.2%
CCI 20:
113.99 4.6%
OBV:
47.76M 2.0%
ROC 12:
142.50% 16.1%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease ("GvHD"), vitiligo and alopecia areata ("AA"). The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric patients with atopic dermatitis. It plans to advance FB-401 into a randomized Phase 2 clinical trial.
Finance Bot
Ask your questions
Start by typing a question below.
